SEC Form 4 · accession 0001805624-26-000002
Pulmonx Corp · LUNG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Glendon E. French III
Officer — President and CEO · Director
Period of report
Jun 1, 2026
Accepted (ET)
Jun 3, 2026 · 4:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001127537
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 1, 2026 | S | 4,171 | $1.54 | D | 1,230,140 | D | |
| Common Stock | Jun 1, 2026 | S | 38,467 | $1.54 | D | 1,191,673 | D | |
| Common Stock | Jun 2, 2026 | S | 13,511 | $1.57 | D | 1,178,162 | D | |
| Common StockF4 | holding | — | — | — | 918,198 | I | By trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2023.
- F2Represents grant of RSUs payable solely in common stock of the Issuer that vests in equal quarterly installments over the three-year period following the date of grant of December 1, 2025.
- F3Represents grant of RSUs payable solely in common stock of the Issuer that vests in equal quarterly installments over the three-year period following the date of grant of June 2, 2025.
- F4The shares are held by the Glendon E French & Gayle French Trustees French Family Rev Trust UA DTD 08/29/2012, of which the reporting person and his spouse are trustees and beneficiaries.